ArticleEuropean urology open science2025

Intraductal Carcinoma Predicts Poor Response to Neoadjuvant Therapy in High-risk Prostate Cancer: A Retrospective Analysis of a Prospective Trial.

Rui M Bernardino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.